新芝生物
(430685)
| 流通市值：8.38亿 | | | 总市值：14.00亿 |
| 流通股本：5479.11万 | | | 总股本：9151.60万 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 160,487,708.6 | 154,428,367.12 | 159,618,680.6 | 129,280,366.78 |
| 应收票据及应收账款 | 11,772,940.27 | 7,236,276.98 | 6,554,491.93 | 9,655,351.73 |
| 其中：应收票据 | 837,813.24 | 719,833.55 | 162,000 | 504,720.8 |
| 应收账款 | 10,935,127.03 | 6,516,443.43 | 6,392,491.93 | 9,150,630.93 |
| 预付款项 | 3,956,330.38 | 4,412,524.08 | 4,567,551.22 | 4,343,584.93 |
| 其他应收款合计 | 1,157,680.23 | 1,102,508.27 | 1,181,498.54 | 1,064,677.27 |
| 存货 | 47,777,249 | 49,726,654.89 | 50,568,975.19 | 47,891,201.06 |
| 其他流动资产 | 2,398,735.22 | 2,630,957.49 | 966,827.47 | 1,335,215.05 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 397,697,796.51 | 426,557,543.14 | 485,042,394.82 | 500,099,224.08 |
| 非流动资产: | | | | |
| 长期股权投资 | 0 | - | - | 0 |
| 其他非流动金融资产 | 40,176,216.28 | - | - | - |
| 固定资产 | 42,606,391.99 | 43,114,445.37 | 44,682,748.06 | 45,786,568.68 |
| 在建工程 | 89,952,119.55 | 84,037,860.99 | 58,773,560.05 | 22,392,851.47 |
| 使用权资产 | 3,834,337.21 | 4,676,547.16 | 5,316,052 | 6,513,144.52 |
| 无形资产 | 21,849,876.24 | 21,653,229.5 | 21,715,753.1 | 21,892,077.89 |
| 商誉 | 6,868,485.01 | 6,868,485.01 | - | - |
| 长期待摊费用 | 1,591,531.5 | 1,805,548.75 | 1,686,641.14 | 2,040,719.82 |
| 递延所得税资产 | 2,329,056.45 | 2,216,304.68 | 6,895,187.57 | 6,902,134.06 |
| 其他非流动资产 | 1,710,835.9 | 1,710,835.9 | 1,710,835.9 | 5,616,294.44 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 210,918,850.13 | 166,083,257.36 | 140,780,777.82 | 111,143,790.88 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 608,616,646.64 | 592,640,800.5 | 625,823,172.64 | 611,243,014.96 |
| 流动负债: | | | | |
| 短期借款 | 0 | - | - | 0 |
| 应付票据及应付账款 | 20,505,894.89 | 25,224,769.53 | 33,750,329.99 | 7,264,545.96 |
| 应付账款 | 20,505,894.89 | 25,224,769.53 | 33,750,329.99 | 7,264,545.96 |
| 合同负债 | 12,776,474.25 | 9,624,938.56 | 10,246,611.27 | 6,060,028.51 |
| 应付职工薪酬 | 12,388,848.55 | 8,897,729.71 | 6,037,939 | 20,570,408.35 |
| 应交税费 | 3,414,933.91 | 1,233,039.75 | 546,783.38 | 4,030,058.69 |
| 其他应付款合计 | 2,271,834.55 | 287,598.21 | 52,517.22 | 50,341.31 |
| 一年内到期的非流动负债 | 3,230,557.56 | 3,191,342.35 | 3,355,043.68 | 3,686,851.71 |
| 其他流动负债 | 1,183,082.63 | 923,999.21 | 740,332.21 | 823,169.72 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 55,771,626.34 | 49,383,417.32 | 54,729,556.75 | 42,485,404.25 |
| 非流动负债: | | | | |
| 长期借款 | 0 | - | - | 0 |
| 租赁负债 | - | 756,605.82 | 1,500,472.33 | 2,236,392.69 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | - | 756,605.82 | 1,500,472.33 | 2,236,392.69 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 55,771,626.34 | 50,140,023.14 | 56,230,029.08 | 44,721,796.94 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 91,515,941 | 91,515,941 | 91,515,941 | 91,515,941 |
| 资本公积 | 352,446,141.5 | 352,285,962.96 | 356,702,211.88 | 356,394,735.77 |
| 减:库存股 | 28,235,967.38 | 28,235,967.38 | 28,235,967.38 | 27,736,004.94 |
| 盈余公积 | 28,934,321.39 | 28,934,321.39 | 28,934,321.39 | 28,934,321.39 |
| 未分配利润 | 74,509,077.02 | 65,916,808.03 | 91,343,101.95 | 88,407,380.75 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 519,169,513.53 | 510,417,066 | 540,259,608.84 | 537,516,373.97 |
| 少数股东权益 | 33,675,506.77 | 32,083,711.36 | 29,333,534.72 | 29,004,844.05 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 552,845,020.3 | 542,500,777.36 | 569,593,143.56 | 566,521,218.02 |
| 负债和股东权益合计 | 608,616,646.64 | 592,640,800.5 | 625,823,172.64 | 611,243,014.96 |
| 公告日期 | 2024-10-29 | 2024-08-27 | 2024-04-26 | 2024-04-22 |
| 审计意见(境内) | | | | 标准无保留意见 |